ATC code A10

ATC code A10 Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup A10 is part of the anatomical group A Alimentary tract and metabolism.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA10.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A10A Insulins and analogues

A10AB Insulins and analogues for injection, fast-acting

A10AB01 Insulin (human)

A10AB02 Insulin (beef)

A10AB03 Insulin (pork)

A10AB04 Insulin lispro

A10AB05 Insulin aspart

A10AB06 Insulin glulisine

A10AB30 Combinations

A10AC Insulins and analogues for injection, intermediate-acting

A10AC01 Insulin (human)

A10AC02 Insulin (beef)

A10AC03 Insulin (pork)

A10AC04 Insulin lispro

A10AC30 Combinations

A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting

A10AD01 Insulin (human)

A10AD02 Insulin (beef)

A10AD03 Insulin (pork)

A10AD04 Insulin lispro

A10AD05 Insulin aspart

A10AD06 Insulin degludec and insulin aspart

A10AD30 Combinations

A10AE Insulins and analogues for injection, long-acting

A10AE01 Insulin (human)

A10AE02 Insulin (beef)

A10AE03 Insulin (pork)

A10AE04 Insulin glargine

A10AE05 Insulin detemir

A10AE06 Insulin degludec

A10AE07 Insulin icodec

A10AE30 Combinations

A10AE54 Insulin glargine and lixisenatide

A10AE56 Insulin degludec and liraglutide

A10AF Insulins and analogues for inhalation

A10AF01 Insulin (human)

A10B Blood glucose lowering drugs, excluding insulins

A10BD02 Metformin and sulfonylureas

A10BD03 Metformin and rosiglitazone

A10BD04 Glimepiride and rosiglitazone

A10BD05 Metformin and pioglitazone

A10BD06 Glimepiride and pioglitazone

A10BD07 Metformin and sitagliptin

A10BD08 Metformin and vildagliptin

A10BD09 Pioglitazone and alogliptin

A10BD10 Metformin and saxagliptin

A10BD11 Metformin and linagliptin

A10BD12 Pioglitazone and sitagliptin

A10BD13 Metformin and alogliptin

A10BD14 Metformin and repaglinide

A10BD15 Metformin and dapagliflozin

A10BD16 Metformin and canagliflozin

A10BD17 Metformin and acarbose

A10BD18 Metformin and gemigliptin

A10BD19 Linagliptin and empagliflozin

A10BD20 Metformin and empagliflozin

A10BD21 Saxagliptin and dapagliflozin

A10BD22 Metformin and evogliptin

A10BD23 Metformin and ertugliflozin

A10BD24 Sitagliptin and ertugliflozin

A10BD25 Metformin, saxagliptin and dapagliflozin

A10BD26 Metformin and lobeglitazone

A10BD27 Metformin, linagliptin and empagliflozin

A10BD28 Metformin and teneligliptin

A10BD29 Sitagliptin and dapagliflozin

A10BF Alpha glucosidase inhibitors

A10BF01 Acarbose

A10BF02 Miglitol

A10BF03 Voglibose

A10BG Thiazolidinediones

A10BG01 Troglitazone

A10BG02 Rosiglitazone

A10BG03 Pioglitazone

A10BG04 Lobeglitazone

A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors

A10BH01 Sitagliptin

A10BH02 Vildagliptin

A10BH03 Saxagliptin

A10BH04 Alogliptin

A10BH05 Linagliptin

A10BH06 Gemigliptin

A10BH07 Evogliptin

A10BH08 Teneligliptin

A10BH51 Sitagliptin and simvastatin

A10BH52 Gemigliptin and rosuvastatin

A10BJ Glucagon-like peptide-1 (GLP-1) analogues

A10BJ01 Exenatide

A10BJ02 Liraglutide

A10BJ03 Lixisenatide

A10BJ04 Albiglutide

A10BJ05 Dulaglutide

A10BJ06 Semaglutide

A10BJ07 Beinaglutide

A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors

A10BK01 Dapagliflozin

A10BK02 Canagliflozin

A10BK03 Empagliflozin

A10BK04 Ertugliflozin

A10BK05 Ipragliflozin

A10BK06 Sotagliflozin

A10BK07 Luseogliflozin

A10BK08 Bexagliflozin

QA10BK90 Velagliflozin

A10BX Other blood glucose lowering drugs, excluding insulins

A10BX01 Guar gum

A10BX02 Repaglinide

A10BX03 Nateglinide

A10BX05 Pramlintide

A10BX06 Benfluorex

A10BX08 Mitiglinide

A10BX15 Imeglimin

A10BX16 Tirzepatide

A10BX17 Carfloglitazar

A10BX18 Dorzagliatin

A10X Other drugs used in diabetes

A10XA Aldose reductase inhibitors

A10XA01 Tolrestat

AA10XX Other drugs used in diabetes

A10XX01 Teplizumab

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code A10". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QA10". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code A10". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QA10". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

ATC code A: Alimentary tract and metabolism
A01 Stomatological preparations A02 Drugs for acid related disorders A03 Drugs for functional gastrointestinal disorders A04 Antiemetics and antinauseants A05 Bile and liver therapy A06 Drugs for constipation A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents A08 Antiobesity preparations, excluding diet products A09 Digestives, including enzymes A10 Drugs used in diabetes A11 Vitamins A12 Mineral supplements A13 Tonics A14 Anabolic agents for systemic use A15 Appetite stimulants A16 Other alimentary tract and metabolism products
Other ATC codes
A B C D G H QI J L M N P R S V